The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.

MLA

Prins, Henrieke A. B., et al. “The BAF Complex Inhibitor Pyrimethamine Reverses HIV-1 Latency in People with HIV-1 on Antiretroviral Therapy.” Science Advances, vol. 9, no. 11, Mar. 2023, p. eade6675. EBSCOhost, https://doi.org/10.1126/sciadv.ade6675.

APA

Prins, H. A. B., Crespo, R., Lungu, C., Rao, S., Li, L., Overmars, R. J., Papageorgiou, G., Mueller, Y. M., Stoszko, M., Hossain, T., Kan, T. W., Rijnders, B. J. A., Bax, H. I., van Gorp, E. C. M., Nouwen, J. L., de Vries-Sluijs, T. E. M. S., Schurink, C. A. M., de Mendonça Melo, M., van Nood, E., … Rokx, C. (2023). The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. Science Advances, 9(11), eade6675. https://doi.org/10.1126/sciadv.ade6675

Chicago

Prins, Henrieke A B, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J Overmars, Grigorius Papageorgiou, et al. 2023. “The BAF Complex Inhibitor Pyrimethamine Reverses HIV-1 Latency in People with HIV-1 on Antiretroviral Therapy.” Science Advances 9 (11): eade6675. doi:10.1126/sciadv.ade6675.